A new study details the completed, 14-patient pilot CTL019 trial, which began in mid 2010. Four CLL patients (29 percent) in the study achieved a complete remission. All the patients in this trial had CLL that had relapsed or continued to progress after receiving multiple conventional FDA approved therapies. (These patients were running out of options!) The link below provides a good but concise summary of the trial results based on information provided by the University of Pennsylvania School of Medicine:
I haven't caught up on all recent The Conversation articles, so thanks for bringing this CAR-T update to our attention. (I edited your reply to remove what could be identifying information in the URL).
Searched clinicaltrials.org for CART trials. 100 in China. 63 in US. 4 in Canada - one of 4 is not actual CART but maple syrup trial...and i am not kidding.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
CAR-T treatment for CLL
POST 4 - CAR-T cell therapy
